Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
76.26
Dollar change
+0.06
Percentage change
0.08
%
IndexRUT P/E47.14 EPS (ttm)1.62 Insider Own2.38% Shs Outstand57.86M Perf Week-4.45%
Market Cap4.42B Forward P/E20.95 EPS next Y3.64 Insider Trans-1.43% Shs Float56.55M Perf Month-2.61%
Income94.41M PEG4.10 EPS next Q0.72 Inst Own100.29% Short Float3.94% Perf Quarter7.93%
Sales1.25B P/S3.52 EPS this Y10.13% Inst Trans2.00% Short Ratio3.38 Perf Half Y15.25%
Book/sh20.77 P/B3.67 EPS next Y9.79% ROA4.73% Short Interest2.23M Perf Year10.31%
Cash/sh10.17 P/C7.50 EPS next 5Y11.50% ROE8.05% 52W Range62.58 - 85.62 Perf YTD0.39%
Dividend Est.- P/FCF39.85 EPS past 5Y15.74% ROI4.54% 52W High-10.93% Beta0.90
Dividend TTM- Quick Ratio3.95 Sales past 5Y7.42% Gross Margin41.78% 52W Low21.86% ATR (14)1.93
Dividend Ex-Date- Current Ratio5.45 EPS Y/Y TTM25.11% Oper. Margin9.84% RSI (14)38.69 Volatility3.17% 2.35%
Employees6950 Debt/Eq0.74 Sales Y/Y TTM9.23% Profit Margin7.53% Recom1.56 Target Price94.22
Option/ShortYes / Yes LT Debt/Eq0.73 EPS Q/Q-17.88% Payout0.00% Rel Volume0.67 Prev Close76.20
Sales Surprise1.20% EPS Surprise5.72% Sales Q/Q11.04% EarningsFeb 28 AMC Avg Volume659.17K Price76.26
SMA20-3.81% SMA50-2.23% SMA2002.35% Trades Volume441,198 Change0.08%
Date Action Analyst Rating Change Price Target Change
Feb-07-24Initiated BofA Securities Neutral $87
Dec-21-23Upgrade Canaccord Genuity Hold → Buy $100
Dec-20-22Downgrade Canaccord Genuity Buy → Hold $73 → $72
Jan-05-21Upgrade Needham Hold → Buy $65
Sep-28-20Upgrade Wells Fargo Underweight → Equal Weight $42
Feb-25-20Downgrade Barrington Research Outperform → Mkt Perform
Feb-03-20Upgrade Raymond James Mkt Perform → Outperform $43
Dec-12-19Downgrade Wells Fargo Market Perform → Underperform $26
Sep-24-19Initiated Oppenheimer Outperform
Sep-10-19Downgrade Raymond James Outperform → Mkt Perform
Mar-01-24 04:32AM
Feb-29-24 11:24AM
11:03AM
07:38AM
Feb-28-24 07:00PM
06:15PM Loading…
06:15PM
05:21PM
04:05PM
04:05PM
Feb-23-24 09:15AM
Feb-21-24 10:00AM
Feb-19-24 08:38AM
Feb-15-24 09:25AM
Jan-31-24 12:10PM
09:50AM
09:55AM Loading…
Jan-30-24 09:55AM
Jan-24-24 01:01PM
Jan-23-24 07:19AM
Jan-16-24 04:05PM
Jan-08-24 09:00AM
Jan-03-24 04:05PM
Dec-27-23 05:11AM
Dec-18-23 04:05PM
Dec-15-23 09:50AM
Dec-11-23 10:25AM
Dec-06-23 09:00AM
Dec-04-23 04:05PM
Nov-15-23 07:28AM
Nov-01-23 09:55AM
Oct-31-23 11:40AM
01:37AM Loading…
Oct-30-23 01:37AM
Oct-27-23 12:20PM
11:16AM
10:51AM
Oct-26-23 07:30PM
05:50PM
05:48PM
04:40PM
04:05PM
07:52AM
Oct-25-23 10:21AM
Oct-12-23 11:55AM
Oct-10-23 11:40AM
09:25AM
Oct-05-23 11:05AM
09:25AM
Sep-19-23 09:00AM
Sep-07-23 07:22AM
Sep-06-23 09:25AM
Aug-30-23 12:46PM
Aug-15-23 01:20PM
Aug-10-23 07:58AM
Aug-08-23 06:50AM
Aug-03-23 09:25AM
Jul-26-23 12:07PM
Jul-25-23 08:00PM
05:45PM
04:43PM
04:05PM
Jul-21-23 06:51AM
Jul-13-23 11:56AM
Jul-11-23 11:40AM
Jul-07-23 07:20AM
Jul-06-23 01:11PM
Jul-03-23 07:51AM
Jun-26-23 10:50AM
Jun-22-23 11:40AM
Jun-21-23 08:00PM
11:35AM
Jun-19-23 10:24AM
Jun-14-23 11:51AM
11:22AM
Jun-13-23 01:59PM
11:22AM
Jun-09-23 01:39PM
Jun-08-23 04:01PM
12:44PM
Jun-07-23 04:23PM
01:53PM
12:52PM
Jun-06-23 12:37PM
10:20AM
Jun-05-23 02:12PM
11:45AM
Jun-02-23 12:44PM
Jun-01-23 11:28AM
11:17AM
10:14AM
May-31-23 12:07PM
12:04PM
May-26-23 11:31AM
10:55AM
May-25-23 02:30PM
02:29PM
May-24-23 01:42PM
10:14AM
May-23-23 11:23AM
11:04AM
11:01AM
May-22-23 11:13AM
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Millner F. AnnDirectorJan 22Option Exercise34.4020,000688,00049,960Jan 24 10:49 AM
Millner F. AnnDirectorJan 22Sale80.0020,0001,600,00029,960Jan 24 10:49 AM
LAMPROPOULOS FRED PPRESIDENT AND CEOAug 25Option Exercise28.20200,0005,640,0001,167,916Aug 29 06:08 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOAug 25Option Exercise28.206,000169,20012,888Aug 29 06:08 PM
Peterson NeilCHIEF OPERATING OFFICERAug 22Option Exercise28.208,000225,6008,000Aug 23 11:32 AM
Peterson NeilCHIEF OPERATING OFFICERAug 22Sale67.918,000543,2880Aug 23 11:32 AM
ANDERSON A SCOTTDirectorAug 09Option Exercise50.5025,0001,262,50071,397Aug 11 05:30 PM
ANDERSON A SCOTTDirectorAug 09Sale69.4022,1801,539,29249,217Aug 11 05:30 PM
Peterson NeilCHIEF OPERATING OFFICERMar 16Option Exercise28.208,000225,6008,000Mar 20 04:44 PM
Peterson NeilCHIEF OPERATING OFFICERMar 16Sale68.758,000550,0000Mar 20 04:44 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOMar 14Sale68.2624,9771,705,052967,916Mar 16 06:01 PM
Voigt Michel JamesCHIEF HUMAN RESOURCES OFFICERMar 14Sale68.312,000136,620515Mar 15 01:34 PM
Ward LynneDirectorMar 08Option Exercise34.462,00068,92017,549Mar 10 06:32 PM
Ward LynneDirectorMar 08Sale66.7111,585772,7895,964Mar 10 06:32 PM
ANDERSON A SCOTTDirectorMar 06Option Exercise29.2015,000438,00062,135Mar 08 12:49 PM
ANDERSON A SCOTTDirectorMar 06Sale66.7415,0001,001,16047,135Mar 08 12:49 PM